Cargando…
Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma
To report clinical manifestations, bleeding point localization, and outcomes of management in 16 patients with 16 instances of intractable epistaxis after radiation therapy for nasopharyngeal carcinoma. Retrospective chart review of 16 patients with nasopharyngeal carcinoma (mean age 52.06 ± 14.37 y...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758511/ https://www.ncbi.nlm.nih.gov/pubmed/23846664 http://dx.doi.org/10.1007/s00405-013-2598-6 |
_version_ | 1782477139334922240 |
---|---|
author | He, Cheng-Cheng Si, Yong-feng Xie, Yu-an Yu, Lei |
author_facet | He, Cheng-Cheng Si, Yong-feng Xie, Yu-an Yu, Lei |
author_sort | He, Cheng-Cheng |
collection | PubMed |
description | To report clinical manifestations, bleeding point localization, and outcomes of management in 16 patients with 16 instances of intractable epistaxis after radiation therapy for nasopharyngeal carcinoma. Retrospective chart review of 16 patients with nasopharyngeal carcinoma (mean age 52.06 ± 14.37 years) with 16 instances of intractable epistaxis during the past 5 years, whose diagnosis was confirmed by angiography (n = 10) or MRI/CT imaging studies and clinical manifestations (n = 6). The mean radiation dose to the affected carotid artery was 101.37 ± 34.85 Gy. Bleeding points were detected in the internal carotid artery (n = 8) or external carotid artery (n = 8). Detachable balloons were used in one affected artery for vascular occlusion; six were treated using an absorbable gelatin sponge (n = 4) or microcoils (diameter 1 mm) (n = 2). Endovascular embolization was successful in seven radiation carotid blowout syndromes with cessation of hemorrhage. One patient underwent external carotid artery ligation and one patient recovered without treatment. The clinical follow-up was 3 months. Therapeutic endovascular embolization of intractable epistaxis is both efficient and safe. It should be considered as the primary treatment modality in intractable epistaxis of nasopharyngeal carcinoma. |
format | Online Article Text |
id | pubmed-3758511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-37585112013-09-04 Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma He, Cheng-Cheng Si, Yong-feng Xie, Yu-an Yu, Lei Eur Arch Otorhinolaryngol Miscellaneous To report clinical manifestations, bleeding point localization, and outcomes of management in 16 patients with 16 instances of intractable epistaxis after radiation therapy for nasopharyngeal carcinoma. Retrospective chart review of 16 patients with nasopharyngeal carcinoma (mean age 52.06 ± 14.37 years) with 16 instances of intractable epistaxis during the past 5 years, whose diagnosis was confirmed by angiography (n = 10) or MRI/CT imaging studies and clinical manifestations (n = 6). The mean radiation dose to the affected carotid artery was 101.37 ± 34.85 Gy. Bleeding points were detected in the internal carotid artery (n = 8) or external carotid artery (n = 8). Detachable balloons were used in one affected artery for vascular occlusion; six were treated using an absorbable gelatin sponge (n = 4) or microcoils (diameter 1 mm) (n = 2). Endovascular embolization was successful in seven radiation carotid blowout syndromes with cessation of hemorrhage. One patient underwent external carotid artery ligation and one patient recovered without treatment. The clinical follow-up was 3 months. Therapeutic endovascular embolization of intractable epistaxis is both efficient and safe. It should be considered as the primary treatment modality in intractable epistaxis of nasopharyngeal carcinoma. Springer Berlin Heidelberg 2013-07-12 2013 /pmc/articles/PMC3758511/ /pubmed/23846664 http://dx.doi.org/10.1007/s00405-013-2598-6 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Miscellaneous He, Cheng-Cheng Si, Yong-feng Xie, Yu-an Yu, Lei Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma |
title | Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma |
title_full | Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma |
title_fullStr | Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma |
title_full_unstemmed | Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma |
title_short | Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma |
title_sort | management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma |
topic | Miscellaneous |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758511/ https://www.ncbi.nlm.nih.gov/pubmed/23846664 http://dx.doi.org/10.1007/s00405-013-2598-6 |
work_keys_str_mv | AT hechengcheng managementofintractableepistaxisinpatientswhoreceivedradiationtherapyfornasopharyngealcarcinoma AT siyongfeng managementofintractableepistaxisinpatientswhoreceivedradiationtherapyfornasopharyngealcarcinoma AT xieyuan managementofintractableepistaxisinpatientswhoreceivedradiationtherapyfornasopharyngealcarcinoma AT yulei managementofintractableepistaxisinpatientswhoreceivedradiationtherapyfornasopharyngealcarcinoma |